報價延遲最少15分鐘:2026/03/10 04:42 EDT
盤前時段
|
||||
|
13.29 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
13.29
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.43/1.68
|
|
企業價值
843.24M
|
| 資產負債 |
|
每股賬面淨值
10.78
|
| 現金流量 |
|
現金流量率
0.10
|
| 損益表 |
|
收益
370.50M
|
|
每股收益
7.87
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF,and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions. |
